|
ZNF430 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.07980000000085E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16210000000472E-05 |
| Normal-vs-Stage2 |
5.375100E-03 |
| Normal-vs-Stage3 |
3.322000E-02 |
| Normal-vs-Stage4 |
4.011000E-04 |
| Stage1-vs-Stage2 |
4.644200E-01 |
| Stage1-vs-Stage3 |
1.348770E-01 |
| Stage1-vs-Stage4 |
3.783400E-01 |
| Stage2-vs-Stage3 |
5.971400E-01 |
| Stage2-vs-Stage4 |
2.157200E-01 |
| Stage3-vs-Stage4 |
1.428360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.87920000000097E-05 |
| Normal-vs-AfricanAmerican |
2.978900E-04 |
| Normal-vs-Asian |
2.685700E-02 |
| Caucasian-vs-AfricanAmerican |
8.782600E-01 |
| Caucasian-vs-Asian |
9.344600E-01 |
| AfricanAmerican-vs-Asian |
8.684400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96459999999288E-05 |
| Normal-vs-Female |
1.148830E-01 |
| Male-vs-Female |
1.400980E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.624440E-03 |
| Normal-vs-Extreme_Weight |
1.860300000045E-06 |
| Normal-vs-Obese |
2.644300E-03 |
| Normal-vs-Extreme_Obese |
9.72820000000318E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.442800E-01 |
| Normal_Weight-vs-Obese |
5.409800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.089850E-01 |
| Extreme_Weight-vs-Obese |
3.043800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.446400E-01 |
| Obese-vs-Extreme_Obese |
7.588000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.988100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.801200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.59525999999799E-05 |
| Normal-vs-Age(81-100Yrs) |
1.85724999999248E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.626000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.612600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.612500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.055970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.717500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.444400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.98339999996678E-07 |
| Normal-VS-Type2 PRCC |
3.34790000000584E-06 |
| Normal-VS-KIRP CIMP |
5.820400E-01 |
| Normal-VS-Unclassified PRCC |
5.183800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.307800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.129500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.705600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.322400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.131900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.445000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.63889995702982E-09 |
| Normal-vs-N1 |
2.555200E-01 |
| Normal-vs-N2 |
4.316300E-03 |
| N0-vs-N1 |
7.162800E-03 |
| N0-vs-N2 |
4.440600E-01 |
| N1-vs-N2 |
1.067560E-01 |
|
|
